CAT 1 · Nutritional Iron Deficiency in Adolescents
CAT 2 · Menorrhagia/Cycle Irregularity as a Contributor
TRIGGERS
SOCIAL / MENTAL / FINANCIAL
LIFESTYLE MODIFICATIONS
Clinical Question: In a 15-year-old girl with a mixed diet and no overt malabsorptive or bleeding history, does dietary iron bioavailability alone provide a sufficient mechanistic explanation for microcytic hypochromic anemia, or must increased physiologic iron demand also be invoked?
Background
Dietary iron exists as heme (fleshy foods) and non-heme (plant-based, phytate-inhibited) forms. In typical regional diets where non-heme iron predominates and inhibitors outweigh enhancers, overall iron absorption is low, commonly cited around 5% of total dietary intake. Adolescence, alongside pregnancy and early childhood, is a period of disproportionately increased iron requirement, making teenage girls a recognized vulnerable group even without additional blood loss.
Appraisal of Evidence
Nutrition-science literature on iron bioavailability supports that absorption depends on the chemical form of iron, the enhancer/inhibitor balance in the diet, and the iron status of the individual — not calorie or protein sufficiency alone. This patient reports a mixed diet with good appetite and no pica, which somewhat limits (but does not exclude) a purely dietary explanation, since even an adequate-appearing mixed diet can be non-heme-iron-dominant and poorly bioavailable. Her prior transfusion 6 years ago for low hemoglobin establishes a longstanding tendency toward iron-deficient erythropoiesis predating the current episode.
| Domain | Supports link | Limits |
|---|
| Dietary pattern | Predominantly non-heme iron diets are a well-established population-level driver of IDA | Patient reports "good appetite," mixed diet — dietary deficiency not directly quantified (no diet recall done) |
| Physiologic demand | Adolescent growth spurt increases iron requirement independent of diet | Growth velocity not documented in this case |
| Prior history | Transfusion 6 years ago for low Hb suggests a recurring predisposition | No documented cause was established for that earlier episode either |
Bottom line: Dietary iron bioavailability plausibly explains a substantial part of the picture, but in an adolescent female with a history of prior anemia and new menstrual irregularity, physiologic demand and possible occult blood loss should be actively examined rather than assumed absent.
Clinical Question: Given that her cycles have become irregular over the past year (though she denies menorrhagia or clots), could unrecognized or underreported menstrual blood loss be contributing meaningfully to her iron deficiency, independent of dietary intake?
Background
Menstrual blood loss is one of the two most common causes of iron deficiency in adolescent and adult women, alongside inadequate dietary intake. Subjective descriptions of flow (pad counts, absence of clots) are known to correlate imperfectly with actual measured blood loss, and cycle irregularity itself can reflect an evolving hypothalamic-pituitary-ovarian axis in early adolescence rather than a fixed, quantifiable pattern.
Appraisal of Evidence
Gynecologic and hematologic literature consistently identifies heavy or irregular menstrual bleeding as a major contributor to iron deficiency in reproductive-age females, and pad-count-based self-report is a recognized but imprecise proxy for volume. This patient's own report (2 pads/day, no clots, no menorrhagia, but new irregularity for 1 year) does not meet the usual clinical threshold for menorrhagia, but the shift from a regular 5/30 cycle to an irregular pattern is itself a change worth tracking rather than dismissing.
| Domain | Supports link | Limits |
|---|
| Reported flow | Consistent, non-heavy self-reported pattern argues against overt menorrhagia | Self-report is an imprecise proxy; true volume unmeasured |
| Cycle change | New irregularity over 1 year is a genuine change from her baseline pattern | Could reflect normal adolescent HPO-axis maturation rather than pathology |
| Combined burden | Even modest, "non-heavy" menstrual loss adds to an already iron-deficient state | Cannot be separated from dietary contribution without a menstrual diary/quantification |
Bottom line: Menstrual factors are a plausible contributing — not necessarily sufficient — cause; the case should be framed as combined nutritional and gynecologic contribution until specifically evaluated, not attributed to diet alone.
Identified Triggers / Contributing Factors
Dietary / Nutritional
Predominantly non-heme iron diet (regional dietary pattern)
No documented iron-rich food fortification
Physiologic
Adolescent growth demand
New menstrual cycle irregularity (1 year)
Historical
Prior blood transfusion for low Hb (6 years ago) — recurrence pattern
Low-grade febrile illness 10 days prior to presentation
No pica, no GI bleeding symptoms (no melena/hematochezia), and no reported weight loss were elicited — these negatives narrow, but do not fully exclude, an occult GI source (see Further Queries).
Social, Mental & Financial Insights
Social
School-going adolescent (9th standard) — anemia-related fatigue may affect school performance/attendance
Mental Health
No psychiatric history elicited in this case; fatigue and giddiness may still affect concentration and mood if unaddressed
Financial / Systemic
Recurrent nutritional anemia (2nd documented episode) may reflect ongoing dietary-access or affordability constraints worth exploring with the family
The case as documented does not report social/financial history in detail — this is flagged as a gap, not a finding (see Further Queries panel).
Lifestyle Modifications
Currently Following
Mixed diet with regular meals (3x/day) and fruit intake
Oral iron/folate replacement (Orofer-XT)
Advisable / Not Yet Adopted
Structured iron-rich, heme-iron-containing meal planning (or vitamin-C co-administration with non-heme meals to boost absorption)
Menstrual cycle diary to quantify and track flow going forward
Deworming assessment given regional endemicity of soil-transmitted helminths as an occult contributor
Repeat CBC at 4–6 weeks to confirm hemoglobin response to therapy
Distinguishing what she is already doing from what remains advisable-but-unstarted highlights where structured follow-up would add the most value.